Old Web
English
Sign In
Acemap
>
authorDetail
>
Ramon Kemp
Ramon Kemp
Merck & Co.
Pharmacology
Medicine
Virus
Raltegravir
Integrase inhibitor
3
Papers
53
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A phase I trial of the human double minute 2 inhibitor (MK-8242) in patients with refractory/recurrent acute myelogenous leukemia (AML).
2015
Journal of Clinical Oncology
Farhad Ravandi
Ivana Gojo
Mrinal M Patnaik
Mark D. Minden
Hagop M. Kantarjian
Amy O. Johnson-Levonas
Craig Fancourt
Raymond Lam
Amy Meister
Mary Elizabeth Jones
Ramon Kemp
Clayton D. Knox
Shelonitda Rose
Payal Shah Patel
Raoul Tibes
Show All
Source
Cite
Save
Citations (5)
Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.
2011
Annals of the New York Academy of Sciences
Bach-Yen Nguyen
Robin Isaacs
Hedy Teppler
Randi Y. Leavitt
Peter Sklar
Marian Iwamoto
Larissa Wenning
Michael D. Miller
Joshua Chen
Ramon Kemp
Wei Xu
Robert A. Fromtling
Joseph P. Vacca
Steven D. Young
Michael Rowley
Michael W. Lower
Keith M. Gottesdiener
Daria J. Hazuda
Show All
Source
Cite
Save
Citations (45)
Pharmacological Antagonism of the Slow‐Activating Delayed Rectifying Potassium Channel (IKs) Has No Effect on Cochlear Structure and Function in vivo
2001
Pharmacology & Toxicology
Craig Whitworth
Leonard P. Rybak
Ramon Kemp
Stan Spence
Show All
Source
Cite
Save
Citations (3)
1